Nippon India Pharma Fund - Direct (G) logo

Nippon India Pharma Fund Direct Growth

NAV ₹582.24 as on 17 Nov 2025

RiskVery High

Fund Size₹8,346.49Cr

NAV₹582.24 as on 17 Nov 2025
RiskVery High
Fund Size₹8,346.49Cr

Download 3-in-1 Torus App
Trade at flat ₹11/order & Zero AMC
demat with one powerful SuperApp.

Investment Details
Top Rated Funds

Lock-in

No Lock-in

Min One Time Amount

₹5,000

Min Withdrawal Amount

₹-

Min SIP Amount

₹100

Min Additional Amount

₹1,000

Exit Load

1% if redeemed or switched out on or before completion of 1 Months from the date of allotment of units. Nil if redeemed or switched out after the completion of 1 Months from the date of allotment of units.

Basic Details

Age

12 years 10 months (Since Jan 02, 2013)

Return since Launch

17.89%

Expense ratio

0.89%

Type

OPEN

AUM (Fund Size)

₹8,346.49

Risk Grade

Very High

Benchmark

BSE Healthcare TRI

Calculate Your Returns
Select Duration
Choose Amount
Returns
Total investment of ₹2,40,000
Would have become ₹61,949 (+209.74%)
Fund Manager

Name:

Sailesh Raj Bhan

Experience:

Mr.Bhan is an MBA with specialization in Finance and CFA. Has over 9 Yrs. of experience in Equity Securities Research & Sequeir Investment Pvt. Ltd. for 5 years and with Emkay Share & stock Broker Pvt. Ltd. for 2 years.

RiskometerLevel of risk in the scheme
Moderate
High
Low
Very
High

Your investment will be at Very High Risk

Fund house & investment objective
Rank (total assets)#4 in India
Total AUM₹6,63,683.96Cr
Date of Incorporation24 Feb 1995
Nippon India Pharma Fund Direct Growth is a Equity Mutual Fund Scheme launched by Nippon India Mutual Fund. This scheme was made available to investors on 02 Jan 2013. The fund currently has an Asset Under Management(AUM) of ₹6,63,683.96 Cr and the Latest NAV as of 17 Nov 2025 is ₹582.24.
The Nippon India Pharma Fund Direct Growth is rated Very High. Minimum SIP Investment is set to ₹100 . Minimum Lumpsum Investment is ₹5,000. Exit load of 1% if redeemed or switched out on or before completion of 1 Months from the date of allotment of units. Nil if redeemed or switched out after the completion of 1 Months from the date of allotment of units..
...Read more
Returns and Rankings

Category: Equity Sectoral / Thematic

1Y3Y5YAll
Fund returns5.64%7.20%3.53%1.38%
Category average8.02%6.14%3.98%-
Rank within category1333466-

FAQ’s

What kind of returns does Nippon India Pharma Fund Direct Growth provide?

Nippon India Pharma Fund Direct Growth has given a return of 23.20% in the past 3 years.

What is the expense ratio charged by Nippon India Pharma Fund Direct Growth?

The Expense Ratio charged by Nippon India Pharma Fund Direct Growth is 0.89%.

What is the AUM size of Nippon India Pharma Fund Direct Growth?

The AUM size of Nippon India Pharma Fund Direct Growth is ₹8,346.49Cr.

What is the minimum SIP amount that you can invest in Nippon India Pharma Fund Direct Growth?

₹100 is the minimum SIP amount that you can invest in Nippon India Pharma Fund Direct Growth .

What are the top stock holdings of Nippon India Pharma Fund Direct Growth?

The top stock holdings of Nippon India Pharma Fund Direct Growth include , Sun Pharmaceutical Industries Ltd , Divis Laboratories Ltd , Lupin Ltd and Cipla Ltd.

Get started with us today and
start building your wealth journey

*By clicking, I agree to the T&C and Whatsapp updates.

Get started with us today and
start building your wealth journey

*By clicking, I agree to the T&C and Whatsapp updates.